SAFETY
Clinical trials for SAFETY explained in plain language.
Never miss a new study
Get alerted when new SAFETY trials appear
Sign up with your email to follow new studies for SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cells from your own tumor could fight cancer
Disease control CompletedThis early-stage study tested a treatment made from a patient's own tumor-fighting immune cells, called tumor-infiltrating lymphocytes (TILs). It included 43 adults with advanced solid tumors like melanoma, cervical cancer, and lung cancer. The goal was to find the safest dose an…
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Immune cell attack: new hope for advanced melanoma patients
Disease control CompletedThis study tested a new treatment called GC101 TIL for people with advanced melanoma that did not respond to standard therapies. The treatment uses a patient's own immune cells, grown in a lab, to fight the cancer. The goal was to check safety and see if tumors shrink. 18 patient…
Matched conditions: SAFETY
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New probiotic passes safety check in early human trial
Knowledge-focused CompletedThis study tested whether a specific probiotic (eK12) is safe for people to take by mouth. It involved 29 healthy adults who were randomly assigned to receive the probiotic or a placebo. Researchers monitored for side effects and changes in vital signs, blood tests, and oral heal…
Matched conditions: SAFETY
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC
-
Experimental skin injection tested for safety in 8 volunteers
Knowledge-focused CompletedThis early-stage study tested whether an investigational product called PEP (Purified Exosome Product) is safe when injected into the skin of healthy adults. Eight volunteers received the injection and were monitored for side effects. The goal was only to check safety, not to tre…
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Clinical Testing of Beverly Hills • Aim: Knowledge-focused
Last updated May 26, 2026 03:10 UTC
-
Pen or syringe? study tests easier way to give pasireotide
Knowledge-focused CompletedThis study tested whether giving the drug pasireotide with a reusable pen device works as well as using a traditional syringe. Forty healthy adults received single doses by both methods. Researchers measured drug levels in the blood and checked for side effects to see if the pen …
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: RECORDATI GROUP • Aim: Knowledge-focused
Last updated May 26, 2026 03:10 UTC
-
Bike cameras reveal how kids ride: new study tests safety training
Knowledge-focused CompletedThis study tested a community bike safety program for 195 kids ages 9 to 12. Some kids took a 12-hour safety class, some took the class plus a parent training session, and others got no training. All bikes had a special GPS and video system to record how kids rode and any close c…
Matched conditions: SAFETY
Phase: NA • Sponsor: Cara J. Hamann • Aim: Knowledge-focused
Last updated May 26, 2026 03:10 UTC
-
New glutathione formula shows promise in absorption study
Knowledge-focused CompletedThis study looked at how well a new micellar glutathione supplement is absorbed by the body compared to standard forms. Sixteen healthy adults took the supplement daily for 30 days. Researchers measured blood levels and checked liver safety. The goal was to see if this new formul…
Matched conditions: SAFETY
Phase: NA • Sponsor: Factors Group of Nutritional Companies Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 03:06 UTC
-
Pregnant women test best timing for COVID and flu shots
Knowledge-focused CompletedThis study looked at whether it's safe for pregnant women to get the COVID-19 and flu vaccines at the same time or if they should wait 1-2 weeks between shots. About 98 pregnant women took part, and researchers tracked side effects and birth outcomes like preterm birth. The goal …
Matched conditions: SAFETY
Phase: PHASE4 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 26, 2026 03:04 UTC
-
New drug Y-3 passes first safety check in small human study
Knowledge-focused CompletedThis early-stage study tested the safety and how the body handles a new drug called Y-3 in 20 healthy adults. Participants received a single dose of 40 mg, 60 mg, or a placebo. The goal was to measure drug levels in the blood and check for any side effects, not to treat a disease…
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
Kratom under the microscope: new study reveals how it affects the body
Knowledge-focused CompletedThis study looked at how safe kratom is and how the body processes it in healthy adults who have used opioids recreationally. Researchers gave single doses of kratom and monitored side effects and drug levels in the blood. The goal was to gather basic safety and processing inform…
Matched conditions: SAFETY
Phase: PHASE1 • Sponsor: Altasciences Company Inc. • Aim: Knowledge-focused
Last updated May 19, 2026 11:49 UTC
-
Brain boost or just a pill? study tests supplements on student smarts
Knowledge-focused CompletedThis study looked at whether taking a dietary supplement for 60 days could improve thinking and mood in 75 university students aged 18 and older. Participants were split into three groups: two received different supplements, and one got a placebo (dummy pill). Researchers checked…
Matched conditions: SAFETY
Phase: NA • Sponsor: Cooperativa de Ensino Superior, Politécnico e Universitário • Aim: Knowledge-focused
Last updated May 08, 2026 12:00 UTC
-
New program boosts safety smarts in preschoolers
Knowledge-focused CompletedThis study tested a special safety education program for 60 children aged 4-5. The program used fun, hands-on activities to teach kids about personal safety and first aid. Parents reported that children who took part learned more about staying safe compared to those who didn't.
Matched conditions: SAFETY
Phase: NA • Sponsor: Karabuk University • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC